Search results for "LEED"

showing 10 items of 267 documents

Clinical efficacy of semiconductor laser application as an adjunct to conventional scaling and root planing.

2005

Background and Objectives: The aim of the in vitro study was to examine the clinical efficacy of semiconductor laser periodontal pocket irradiation as an adjunct to conventional scaling and root planing. Materials and Methods: Twenty-two healthy patients with a need of periodontal treatment (15 women, 7 men, mean age 45.0� 10.8 years) with at least four teeth in all quadrants, were included. All of them underwent a conventional periodontal treatment including scaling and root planing. Using a split mouth design, two randomly chosen quadrants (one upper and the corresponding lower one) were subsequently treated with an 809 nm GaAlAs laser operated at a power output of 1.0 Watt using a 0.6 mm…

AdultMaleGingival and periodontal pocketmedicine.medical_treatmentBleeding on probingDentistryDermatologySensitivity and SpecificityStatistics NonparametricRoot PlaningTooth mobilityScaling and root planingMedicineHumansPeriodontal PocketProspective StudiesLow-Level Light TherapyProspective cohort studySalineProbabilityPeriodontitisbusiness.industryMiddle Agedmedicine.diseaseCombined Modality TherapyTreatment OutcomeClinical attachment lossCase-Control StudiesDental ScalingSurgeryFemalemedicine.symptombusinessFollow-Up StudiesLasers in surgery and medicine
researchProduct

Ketorolac, diclofenac, and ketoprofen are equally safe for pain relief after major surgery

2002

Background Ketorolac is approved for the relief of postoperative pain but concerns have been raised over a possible risk of serious adverse effects and death. Two regulatory reviews in Europe on the safety of ketorolac found the data were inconclusive and lacked comparison with other non-steroidal anti-inflammatory drugs. The aim of this study was to compare the risk of serious adverse effects with ketorolac vs diclofenac or ketoprofen in adult patients after elective major surgery. Methods This prospective, randomized multicentre trial evaluated the risks of death, increased surgical site bleeding, gastrointestinal bleeding, acute renal failure, and allergic reactions, with ketorolac vs di…

AdultMaleKetoprofenGastrointestinal bleedingmedicine.medical_specialtyDiclofenacAnalgesicBlood Loss Surgicallaw.inventionDrug HypersensitivityDiclofenacRandomized controlled trialRisk FactorslawmedicineHumansCyclooxygenase InhibitorsProspective StudiesAdverse effectAgedAged 80 and overPain Postoperativebusiness.industryAnti-Inflammatory Agents Non-SteroidalAnticoagulantsAcute Kidney InjuryMiddle Agedmedicine.diseaseSurgerybody regionsKetorolacClinical trialstomatognathic diseasesAnesthesiology and Pain MedicineKetoprofenAnesthesiaFemalebusinessKetorolacmedicine.drug
researchProduct

Secondary prophylaxis vs. on-demand treatment to improve quality of life in severe adult haemophilia A patients: a prospective study in a single cent…

2013

Background Retrospective publications show a decrease in the bleeding frequency and an improvement in the quality of life (QoL) in severe adult haemophilia A (SAHA) after switching from the on-demand treatment (DT) to secondary prophylaxis (SP). But there are no prospective studies which demonstrate, using a haemophilia-specific questionnaire, an improvement in the QoL after such treatment change. The main objective of this study is to prospectively compare the QoL and the musculoskeletal assessment after switching from DT to SP in SAHA using the A36 Hemofilia-QoL®. As secondary objective, we compare the haemarthrosis frequency and factor VIII consumption in DT and SP during a similar perio…

AdultMalePediatricsmedicine.medical_specialtyHaemophilia Ahaemophilia AHemorrhageHemophilia AQuality of lifeSurveys and QuestionnairesHemarthrosismedicineHumansProspective StudiesProspective cohort studyRetrospective StudiesmusculoskeletalFactor VIIIbusiness.industrySecondary prophylaxisHematologyGeneral MedicineMiddle Agedmedicine.diseasehumanitiesbleeding incidenceSingle centreOn demand treatmentquality of lifesecondary prophylaxisQuality of LifeFemalebusinessVox sanguinis
researchProduct

Clinical and microbiological findings in patients with peri-implantitis: a cross-sectional study

2015

Objective The aim of this study was to analyze clinical and microbiological characters in subjects and implants affected and not affected by peri-implantitis. Additionally, same features were analyzed also intra-individually, comparing healthy and diseased implants within the same subject. Materials and methods A total of 534 patients who received at least 1 implant and coming to routine check-up or spontaneous visits at the University of Valencia were recruited. Clinical parameters including Bleeding on probing (BoP), Probing pocket depth (PPD), and Pi were screened. Samples for microbiological analysis were obtained from three locations: peri-implant sulci (PIS), inner parts of the implan…

AdultMalePeri-implantitisCross-sectional studymedicine.medical_treatmentBleeding on probingkeratinized mucosaDentistryReal-Time Polymerase Chain ReactionOral hygiene03 medical and health sciences0302 clinical medicineRisk FactorsBoP keratinized mucosa microbiota peri-implantitisPrevalencemicrobiotamedicineHumansIn patientDental implantAgedRetrospective StudiesAged 80 and overbusiness.industryIncidence030206 dentistryMiddle AgedCross-Sectional StudiesSpainAttached gingiva030220 oncology & carcinogenesisFemaleImplantOral Surgerymedicine.symptombusinessBoPperi-implantitisClinical Oral Implants Research
researchProduct

Endoscopic sclerotherapy for hemostasis of acute esophageal variceal bleeding.

2014

Introduction. Currently the most widely used methods for endoscopic control of esophageal varices bleeding are sclerotherapy and rubber band ligation. Although the superiority of band ligation (BL) over endoscopic sclerotherapy (SCL) for the secondary prophylaxis of variceal hemorrhage has been proven, the best approach for acute bleeding remains controversial. Patients and methods. We performed a retrospective study between January 2005 and May 2013. We selected 104 patients with gastrointestinal hemorrhage from rupture of esophageal varices treated with endoscopic sclerotherapy. The sclerosing agent used was 1% polidocanol in 89 cases, butyl-cyanoacrylate in 8 cases and sodium tetradecyls…

AdultMalePolidocanolReproducibility of ResultsEnbucrilateMiddle Agedendoscopic sclerotherapyEsophageal and Gastric VaricesSclerosing SolutionsPolyethylene GlycolsSodium Tetradecyl SulfateTreatment OutcomeRecurrenceSclerotherapyHumansFemaleOriginal ArticleEsophagoscopyGastrointestinal Hemorrhageesophageal variceal bleedingLigationAgedRetrospective Studies
researchProduct

Effect of non-surgical periodontal treatment with or without doxycycline on the periodontium of type 1 diabetic patients

2005

Aim: The present investigation was performed to study how type 1 diabetics responded to non-surgical periodontal treatment with and without adjunctive doxycycline. Method: Sixty diabetic type 1 patients (mean age 35.3 +/- 9 years) with moderate-to-severe periodontal disease were selected and divided into two groups of 30 patients each. Both groups were sex and age matched and had similar amounts of periodontal destruction. Plaque index (PI), bleeding on probing (BOP), probing depth (PD) and clinical attachment levels (CAL) were recorded. Group 1 (30 patients) was treated with oral hygiene instruction, scaling and root planing, chlorhexidine rinses twice a day and doxycycline (100 mg/day for…

AdultMaleTime Factorsroot planingBleeding on probingperiodontal diseaseDentistrylaw.inventionDiabetes ComplicationsScaling and root planingRandomized controlled triallawDiabetes mellitusmedicineHumansSingle-Blind MethodPeriodontal DiseasesDoxycyclinediabetesdoxycyclinebusiness.industryDental Plaque IndexChlorhexidinePeriodontiumMiddle Agedmedicine.diseaseDental Plaque IndexAnti-Bacterial AgentsDiabetes Mellitus Type 1Treatment OutcomeDental Care for Chronically IllDoxycyclineDental ScalingPeriodonticsFemaleperiodontal therapyPeriodontal Indexmedicine.symptombusinessmedicine.drugJournal of Clinical Periodontology
researchProduct

Effect of EDTA root conditioning on the healing of intrabony defects treated with an enamel matrix protein derivative.

2006

Contains fulltext : 49580.pdf (Publisher’s version ) (Open Access) BACKGROUND: Regenerative periodontal therapy with an enamel matrix protein derivative (EMD) has been shown to promote regeneration in intrabony periodontal defects. However, in most clinical studies, root surface conditioning with EDTA was performed in conjunction with the application of EMD, and, therefore, it cannot be excluded that the results may also be attributable to the effect of the root conditioning procedure. The purpose of this study was to determine the effect of root conditioning on the healing of intrabony defects treated with EMD. METHODS: Twenty-four patients, each of whom exhibited one deep intrabony defect…

AdultMaleTissue engineering and reconstructive surgery [UMCN 4.3]Bone RegenerationRoot surfaceOral Surgical ProceduresBleeding on probingAlveolar Bone LossDentistryDerivativeDental Enamel ProteinsDouble-Blind MethodmedicineHumansProspective StudiesTooth RootEdetic AcidChelating AgentsEnamel paintbusiness.industryChemistryOpen flap debridementAttachment levelGingival indexvisual_artvisual_art.visual_art_mediumPeriodonticsConditioningFemalePeriodontal Indexmedicine.symptombusiness
researchProduct

Treatment of severe von Willebrand disease with a high‐purity von Willebrand factor concentrate (Wilfactin®): a prospective study of 50 patients

2007

Background and objectives: A plasma-derived von Willebrand factor (VWF) concentrate with low factor VIII (FVIII) content was specifically developed to treat von Willebrand disease (VWD). Efficacy and safety were investigated by merging the results of two comparable protocols conducted prospectively in 5 European and 12 French centers. Methods and results: Fifty patients with clinically severe VWD (72% had VWF ristocetin cofactor activity less than 10 IU dL(-1) and 46% had FVIII < 20 IU dL(-1)) were treated with the concentrate as the only therapy, except for clinical situations requiring a priming dose of FVIII to rapidly correct an intrinsic coagulation defect. A total of 139 spontaneous b…

AdultMalecongenital hereditary and neonatal diseases and abnormalitiesmedicine.medical_specialtyAdolescentHemorrhagePostoperative HemorrhageGastroenterologyVon Willebrand factorhemic and lymphatic diseasesInternal medicinevon Willebrand FactormedicineVon Willebrand diseaseHumansProspective StudiesChildProspective cohort studyAgedAged 80 and overHemostasisBleeding episodesFactor VIIIbiologybusiness.industryHematologyMiddle Agedmedicine.diseaseSurgeryClinical trialvon Willebrand DiseasesCoagulationChild PreschoolHemostasisConcomitantbiology.proteinFemaleSafetybusinessJournal of Thrombosis and Haemostasis
researchProduct

The adjunctive use of a controlled-release chlorhexidine chip following treatment with a new ultrasonic device in supportive periodontal therapy: a p…

2007

Abstract:  Objective:  The aim of this randomised, split-mouth, controlled clinical trial was to evaluate the effectiveness of a controlled-release chlorhexidine chip (CHX chip) as an adjunctive therapy to scaling and root planing (SRP) with a newly developed ultrasonic device in supportive periodontal therapy (SPT). Materials and methods:  Twenty patients with moderate-to-severe chronic periodontitis, displaying at least four sites with probing depth (PD) ≥5 mm and persistent bleeding on probing (BOP), were recruited for the study. The target sites were randomly treated with either a newly developed piezo-driven ultrasonic device VectorTM- or ultrasonic system (VUS) + CHX chip or VUS alone…

AdultMalemedicine.drug_classUltrasonic TherapyBleeding on probingDental PlaqueDentistryUltrasonic deviceScaling and root planingAntisepticPeriodontal Attachment LossmedicineHumansDentistry (miscellaneous)Periodontal Diseasesbusiness.industryChlorhexidineChlorhexidineMiddle Agedmedicine.diseaseCombined Modality TherapyControlled releaseChronic periodontitisClinical trialDelayed-Action PreparationsAnti-Infective Agents LocalDental ScalingFemalemedicine.symptomEpidemiologic Methodsbusinessmedicine.drugInternational Journal of Dental Hygiene
researchProduct

Role of clinical and laboratory parameters for treatment choice in patients with inherited FVII deficiency undergoing surgical procedures: evidence f…

2018

Perioperative bleeding is a major concern in patients with factor VII (FVII) deficiency. Evaluating data of 95 FVII-deficient patients undergoing 110 surgical procedures (61 major, 49 minor), we assessed the impact of type of surgery, bleeding phenotype and FVII coagulant activity (FVII:C) levels on perioperative replacement therapy (RT). Compared to those with higher FVII:C levels, patients with &lt;3% FVII:C received a higher number of RT doses (8 vs. 2, P = 0·003) for a longer RT duration (3 days vs. 1 day, P = 0·001), with no difference in RT dose. Similarly, patients with a history of major bleeds received a higher number of RT doses (8·5 vs. 2-3, P = 0·013) for a longer RT duration (2…

AdultMalemedicine.medical_specialtyAdolescentClinical Decision-MakingSocio-culturaleHemorrhage030204 cardiovascular system & hematologyIndependent predictorGastroenterologyAsymptomaticsurgery03 medical and health scienceschemistry.chemical_compoundYoung Adult0302 clinical medicineInternal medicinemedicineHumansIn patientRegistriesFactor VII deficiencybleeding disordersbleeding disorderSurgical ProceduresFactor VIIbusiness.industryDisease ManagementPerioperativeHematologySurgical proceduresFactor VIIMiddle AgedCombined Modality TherapyOperativefactor VII deficiencyTreatment Outcomechemistry030220 oncology & carcinogenesisSurgical Procedures Operativebleeding disorders; factor VII deficiency; surgery; Adolescent; Adult; Clinical Decision-Making; Combined Modality Therapy; Disease Management; Factor VII; Factor VII Deficiency; Female; Hemorrhage; Humans; Male; Middle Aged; Registries; Surgical Procedures Operative; Symptom Assessment; Treatment Outcome; Young Adult; HematologyFemalemedicine.symptomSymptom AssessmentbusinessMajor bleeding
researchProduct